Industry / South Korea
'Scientists' Jeopardise Biotechnology Sector
April 2009 | Industry Trend AnalysisA scientific paper on a diabetes gene therapy written by South Korean scientists in 2000 has been retracted by the prestigious journal Nature. BMI notes that this is the second time researchers from the Asian country have been embroiled in controversy. The prospects for South Korea's life science industry are therefore once again at
To read the full article, please sign in or take a free trial.



